These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1702586)

  • 1. Further studies on the immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax.
    Collins WE; Nussenzweig RS; Ruebush TK; Bathurst IC; Nardin EH; Gibson HL; Campbell GH; Barr PJ; Broderson JR; Skinner JC
    Am J Trop Med Hyg; 1990 Dec; 43(6):576-83. PubMed ID: 1702586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory activity against sporozoites induced by antibodies directed against nonrepetitive regions of the circumsporozoite protein of Plasmodium vivax.
    Millet P; Chizzolini C; Wirtz RA; Bathurst I; Broderson JR; Campbell GH; Collins WE
    Eur J Immunol; 1992 Feb; 22(2):519-24. PubMed ID: 1371470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
    Yang C; Collins WE; Xiao L; Saekhou AM; Reed RC; Nelson CO; Hunter RL; Jue DL; Fang S; Wohlhueter RM; Udhayakumar V; Lal AA
    Vaccine; 1997 Mar; 15(4):377-86. PubMed ID: 9141208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax.
    Collins WE; Nussenzweig RS; Ballou WR; Ruebush TK; Nardin EH; Chulay JD; Majarian WR; Young JF; Wasserman GF; Bathurst I
    Am J Trop Med Hyg; 1989 May; 40(5):455-64. PubMed ID: 2658634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal pathology in Saimiri monkeys during a vaccine trial using the recombinant circumsporozoite protein of Plasmodium vivax.
    Tegoshi T; Broderson JR; Iseki M; Oo MM; Collins WE; Aikawa M
    Am J Trop Med Hyg; 1991 Apr; 44(4):406-12. PubMed ID: 2042706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing of Plasmodium vivax CS proteins in Saimiri monkeys.
    Collins WE
    Bull World Health Organ; 1990; 68 Suppl(Suppl):42-6. PubMed ID: 2094590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of sporozoite-specific memory cells in mice immunized with a recombinant Plasmodium vivax circumsporozoite protein.
    Nardin EH; Barr PJ; Gibson HL; Collins WE; Nussenzweig RS; Nussenzweig V
    Eur J Immunol; 1987 Dec; 17(12):1763-7. PubMed ID: 3319650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell epitopes of the circumsporozoite protein of Plasmodium vivax. Recognition by lymphocytes of a sporozoite-immunized chimpanzee.
    Nardin E; Clavijo P; Mons B; van Belkum A; Ponnudurai T; Nussenzweig RS
    J Immunol; 1991 Mar; 146(5):1674-8. PubMed ID: 1704402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence.
    Charoenvit Y; Collins WE; Jones TR; Millet P; Yuan L; Campbell GH; Beaudoin RL; Broderson JR; Hoffman SL
    Science; 1991 Feb; 251(4994):668-71. PubMed ID: 1704150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and cellular immune responses to the circumsporozoite protein of Plasmodium vivax in Madagascar.
    Migot F; Millet P; Chougnet C; Lepers JP; Deloron P
    Am J Trop Med Hyg; 1993 Apr; 48(4):524-9. PubMed ID: 7683178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity induced in squirrel monkeys with a multiple antigen construct against the circumsporozoite protein of Plasmodium vivax.
    Collins WE; Sullivan JS; Morris CL; Galland GG; Jue DL; Fang S; Wohlhueter R; Reed RC; Yang C; Hunter RL; Lal AA
    Am J Trop Med Hyg; 1997 Feb; 56(2):200-10. PubMed ID: 9080881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular proliferative responses in squirrel monkeys immunized with recombinant and synthetic Plasmodium vivax circumsporozoite peptides.
    Procell P; Bathurst IC; Lowell G; Ruebush TK; Skinner JC; Hightower AW; Collins WE
    Am J Trop Med Hyg; 1991 Jun; 44(6):632-9. PubMed ID: 1858966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a polymorphic strain of Plasmodium vivax in monkeys.
    Collins WE; Sattabongkot J; Wirtz RA; Skinner JC; Broderson JR; Millet PG; Morris CL; Richardson BB; Sullivan J; Filipski VK
    J Parasitol; 1992 Jun; 78(3):485-91. PubMed ID: 1597793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a Plasmodium vivax sporozoite vaccine.
    Gordon DM; Cosgriff TM; Schneider I; Wasserman GF; Majarian WR; Hollingdale MR; Chulay JD
    Am J Trop Med Hyg; 1990 Jun; 42(6):527-31. PubMed ID: 1695491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive cellular immune response to circumsporozoite proteins of Plasmodium vivax and P. falciparum in malaria-exposed individuals.
    Carvalho LH; Fontes CJ; Fernandes AA; Marinuzzi HC; Krettli AU
    Parasite Immunol; 1997 Feb; 19(2):47-59. PubMed ID: 9076807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low immunogenicity of a Plasmodium vivax circumsporozoite protein epitope bound by a protective monoclonal antibody.
    Jones TR; Yuan LF; Marwoto HA; Gordon DM; Wirtz RA; Hoffman SL
    Am J Trop Med Hyg; 1992 Dec; 47(6):837-43. PubMed ID: 1471743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei.
    Romero PJ; Tam JP; Schlesinger D; Clavijo P; Gibson H; Barr PJ; Nussenzweig RS; Nussenzweig V; Zavala F
    Eur J Immunol; 1988 Dec; 18(12):1951-7. PubMed ID: 2464495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory activity against Plasmodium vivax sporozoites induced by plasma from Saimiri monkeys immunized with circumsporozoite recombinant proteins or irradiated sporozoites.
    Millet P; Collins WE; Broderson JR; Bathurst I; Nardin EH; Nussenzweig RS
    Am J Trop Med Hyg; 1991 Jul; 45(1):44-8. PubMed ID: 1907809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66.
    Millet P; Campbell GH; Sulzer AJ; Grady KK; Pohl J; Aikawa M; Collins WE
    Am J Trop Med Hyg; 1993 Mar; 48(3):424-31. PubMed ID: 7682382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant.
    Yang C; Collins WE; Sullivan JS; Kaslow DC; Xiao L; Lal AA
    Infect Immun; 1999 Jan; 67(1):342-9. PubMed ID: 9864235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.